TandemLife
Pittsburgh, Pennsylvania, United States
About TandemLife
TandemLife develops, manufactures, and markets innovative medical device products to provide Cardiologists and Cardiac Surgeons from around the world with unique solutions for patients requiring circulatory support. The FDA-cleared TandemHeart® System delivers extracorporeal circulatory support in just minutes... not hours. Used by cardiologists in the cath lab and by cardiac surgeons in the OR (operating room), TandemHeart® can provide up to 5.0 lpm of circulatory support when used percutaneously, and up to 8.0 lpm of circulatory support with a direct surgical cannulation method. TandemHeart® is comprised of three major sub-systems: (1) the TandemHeart® Pump provides circulating power to pull oxygenated blood from the left atrium and to return it to the systemic arterial circulation; (2) the TandemHeart® Cannulae Set connects the pump to the body by way of two percutaneous access points in the patient’s groin; and (3) the TandemHeart® Controllers provide operating power to the pump, provides a controlled flow of lubricant to the pump, and also provides automatic system-monitoring and alarms that indicate conditions which require immediate attention
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: M&A
- Last round: Series Unknown (Jan 2001)
- Website: tandemlife.com
- Phone: (412)963-7770
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/tandemlife-2593611 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.